Cetera Investment Advisers’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$610K Buy
56,361
+472
+0.8% +$4.04K ﹤0.01% 3326
2025
Q4
$341K Buy
55,889
+3,317
+6% +$19.8K ﹤0.01% 3782
2025
Q3
$272K Sell
52,572
-412
-0.8% -$2.37K ﹤0.01% 3912
2025
Q2
$314K Buy
+52,984
New +$319K ﹤0.01% 3356

Other funds holding PTEN

Cetera Investment Advisers's PTEN Position: Q1 2026 in Review

Cetera Investment Advisers increased its Patterson-UTI (PTEN) stake by 0.84% in Q1 2026, buying an estimated $4.04K and bringing the position to 56,361 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

Cetera Investment Advisers first reported a position in PTEN in Q2 2025 and has held it in 4 quarters since. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Cetera Investment Advisers held 56,361 shares of Patterson-UTI worth $610K as of Q1 2026.
  • Cetera Investment Advisers bought 472 Patterson-UTI shares in Q1 2026, an estimated $4.04K.
  • Patterson-UTI made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3326 holding.
  • Cetera Investment Advisers first reported a position in Patterson-UTI in Q2 2025 and has held it in 4 quarters since.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.